122 related articles for article (PubMed ID: 2120745)
1. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
Brackett DJ; Schaefer CF; Lerner MR; Holaday JW; Fagraeus L; Wilson MF
Regul Pept; 1990 Jul; 29(2-3):153-62. PubMed ID: 2120745
[TBL] [Abstract][Full Text] [Related]
2. Cardiorespiratory alterations produced by centrally administered thyrotropin-releasing hormone during canine endotoxin shock.
Leffew SD; Williams CD; Janssen HF
Circ Shock; 1987; 21(3):225-32. PubMed ID: 3105908
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl sulfoxide antagonizes hypotensive, metabolic, and pathologic responses induced by endotoxin.
Brackett DJ; Lerner MR; Wilson MF
Circ Shock; 1991 Mar; 33(3):156-63. PubMed ID: 2044208
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock.
Holaday JW; Ruvio BA; Faden AI
Eur J Pharmacol; 1981 Aug; 74(1):101-5. PubMed ID: 6797829
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock.
Holaday JW; Faden AI
Regul Pept; 1983 Oct; 7(2):111-25. PubMed ID: 6419292
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
Gurll NJ; Holaday JW; Reynolds DG; Ganes E
Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
[TBL] [Abstract][Full Text] [Related]
7. The benefits of corticosteroid given after the onset of hypotension during endotoxin shock in the conscious rat.
Schaefer CF; Brackett DJ; Wilson MF
Adv Shock Res; 1983; 10():183-94. PubMed ID: 6349297
[TBL] [Abstract][Full Text] [Related]
8. Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamine.
Schaefer CF; Brackett DJ; Biber B; Lerner MR; Holaday JW; Wilson MF; Fagraeus L
Regul Pept; 1989 Mar; 24(3):269-82. PubMed ID: 2496439
[TBL] [Abstract][Full Text] [Related]
9. An assessment of plasma histamine concentrations during documented endotoxic shock.
Brackett DJ; Hamburger SA; Lerner MR; Jones SB; Schaefer CF; Henry DP; Wilson MF
Agents Actions; 1990 Nov; 31(3-4):263-74. PubMed ID: 2085142
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of central choline during endotoxin shock in the rat.
Savci V; Ulus IH
J Cardiovasc Pharmacol; 1997 Nov; 30(5):667-75. PubMed ID: 9388050
[TBL] [Abstract][Full Text] [Related]
11. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
Qi M; Jones SB
Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
[TBL] [Abstract][Full Text] [Related]
12. Effects of naloxone and thyrotropin-releasing hormone on plasma catecholamines, corticosterone, and arterial pressure in normal and endotoxemic rats.
Long JB; Lake CR; Reid AA; Holaday JW
Circ Shock; 1986; 18(1):1-10. PubMed ID: 3080257
[TBL] [Abstract][Full Text] [Related]
13. The effects of H1 and H2 histamine receptor antagonists on the development of endotoxemia in the conscious, unrestrained rat.
Brackett DJ; Schaefer CF; Wilson MF
Circ Shock; 1985; 16(2):141-53. PubMed ID: 2414028
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and respiratory effects of thyrotropin-releasing hormone and epinephrine in anaphylactic shock.
Muelleman RL; Gatz M; Salomone JA; Herndon B; Salzman GA
Ann Emerg Med; 1989 May; 18(5):534-41. PubMed ID: 2497665
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing hormone increases survival in canine hemorrhagic shock.
Sugiura A; Smith RA; Shatney CH
J Surg Res; 1986 Jan; 40(1):63-8. PubMed ID: 3079847
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation.
Kaufmann U; Schapira M; Waeber B; Nussberger J; Brunner HR
Circ Shock; 1987; 23(3):215-23. PubMed ID: 2448054
[TBL] [Abstract][Full Text] [Related]
17. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
[TBL] [Abstract][Full Text] [Related]
18. Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
Cunha-Goncalves D; Perez-de-Sa V; Larsson A; Thörne J; Blomquist S
Anesth Analg; 2009 Nov; 109(5):1576-83. PubMed ID: 19713252
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat.
Sirén AL; Powell E; Feuerstein G
Am J Physiol; 1986 Jun; 250(6 Pt 2):H1093-101. PubMed ID: 3087219
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and metabolic effects of vasopressin blockade in endotoxin shock.
Matsuoka T; Wisner DH
Surgery; 1997 Feb; 121(2):162-73. PubMed ID: 9037228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
